Mitoferrin-1 Promotes Proliferation and Abrogates Protein Oxidation via the Glutathione Pathway in Glioblastoma

Md Yousuf Ali1, Corinne E Griguer1,2, Susanne Flor1,2

  • 1Interdisciplinary Graduate Program in Human Toxicology, The University of Iowa, Iowa City, IA 52242, USA.

Insights

Mitochondrial iron transporter MFRN1 promotes glioblastoma (GBM) progression by increasing mitochondrial iron and glutathione levels. Targeting MFRN1 may offer a new therapeutic strategy for GBM patients.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Glioblastoma (GBM) exhibits poor patient survival due to therapeutic resistance.
  • Cytosolic labile iron pool reduction is linked to radioresistance.
  • Iron metabolism, particularly mitochondrial iron, influences reactive oxygen species (ROS) production, tumor progression, and therapy response.

Purpose of the Study:

  • Investigate the role of mitochondrial iron transporters mitoferrin-1 (MFRN1) and mitoferrin-2 (MFRN2) in GBM progression.
  • Determine the correlation between MFRN1/MFRN2 expression and patient survival.
  • Elucidate the mechanistic link between MFRN1 and GBM aggressiveness.

Main Methods:

  • Analysis of The Cancer Genome Atlas (TCGA) database for MFRN1 and MFRN2 mRNA expression in GBM.
  • Overexpression of MFRN1 in glioma cells.
  • Assessment of mitochondrial iron levels, cell proliferation, and anchorage-independent growth.
  • Evaluation of mouse survival in an orthotopic glioma model.
  • Measurement of glutathione levels and protein damage.

Main Results:

  • GBM tissue shows increased MFRN1 mRNA and decreased MFRN2 mRNA compared to non-GBM tissue.
  • Higher MFRN1 mRNA levels correlate with reduced overall survival in GBM patients.
  • MFRN1 overexpression in glioma cells increases mitochondrial iron, enhances proliferation and anchorage-independent growth, and decreases survival in mice.
  • MFRN1 overexpression upregulates glutathione, conferring protection against protein damage.

Conclusions:

  • Mitochondrial iron transporter MFRN1 plays a crucial role in GBM progression.
  • MFRN1-mediated mitochondrial iron metabolism is mechanistically linked to GBM aggressiveness.
  • Targeting MFRN1 presents a potential therapeutic strategy to improve outcomes for GBM patients.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.2K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K